Dr Tushar Salukhe | Royal Brompton & Harefield Hospitals Education

Dr Tushar Salukhe

Consultant cardiologist and electrophysiologist
Specialises in cardiac electrophysiology, treating arrhythmia and implanting cardiac devices.

Dr Tushar Salukhe is a consultant cardiologist and electrophysiologist at Royal Brompton and Harefield hospitals.

He obtained a first-class degree in medical science in 1995 from Imperial College London, and in 1998 qualified in medicine with distinctions. Soon after, he trained in internal medicine and received his membership to the Royal College of Physicians (MRCP). Dr Salukhe then won funding from the British Heart Foundation (BHF) to pursue his doctorate in pacing therapies for heart failure at the National Heart and Lung Institute.

In 2008, Dr Salukhe gained his MD and continued researching as a fundamental element to his training. His specialist training included cardiology and electrophysiology at prominent centres, such as Royal Brompton, Hammersmith and St Mary’s hospitals in London.

Clinical expertise

Dr Tushar Salukhe treats patients who suffer with problems of heart rhythm or palpitations.

His areas of expertise include:

  • care and treatment of patients with cardiac arrhythmias
  • advanced mapping and ablation
  • implantation of complex cardiac devices
  • implantation of defibrillators and biventricular pacemakers
  • ablation of atrial arrhythmia, in specific atrial fibrillation
  • care and treatment of patients with vasovagal syncope (fainting or transient loss of consciousness)
  • cardiac electrophysiology.

In addition to clinical electrophysiology, Dr Salukhe leads the syncope service and non-invasive ECG monitoring at Royal Brompton and Harefield hospitals.


A complete list of Dr Salukhe’s publications is available on PubMed.


Dr Tushar Salukhe is an honorary senior lecturer at the National Heart and Lung Institute, Imperial College London.

Additionally, he organises various training day programmes at the Royal Society of Medicine. His academic interests are:

  • ablation endpoints for ablation of atrial fibrillation
  • novel treatment for vasovagal syncope.